Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$4.17 - $5.74 $704,809 - $970,169
-169,019 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$5.28 - $9.64 $67,261 - $122,803
-12,739 Reduced 7.01%
169,019 $892,000
Q4 2020

Feb 12, 2021

SELL
$5.75 - $7.13 $113,263 - $140,446
-19,698 Reduced 9.78%
181,758 $1.19 Million
Q3 2020

Nov 16, 2020

SELL
$4.9 - $7.12 $7,016 - $10,195
-1,432 Reduced 0.71%
201,456 $1.23 Million
Q2 2020

Aug 14, 2020

SELL
$6.43 - $9.86 $100,365 - $153,904
-15,609 Reduced 7.14%
202,888 $1.47 Million
Q1 2020

May 15, 2020

BUY
$6.36 - $10.05 $9,851 - $15,567
1,549 Added 0.71%
218,497 $1.52 Million
Q4 2019

Feb 14, 2020

BUY
$8.49 - $12.81 $4,168 - $6,289
491 Added 0.23%
216,948 $1.91 Million
Q3 2019

Nov 14, 2019

SELL
$5.58 - $14.47 $212,196 - $550,265
-38,028 Reduced 14.94%
216,457 $2.42 Million
Q2 2019

Aug 14, 2019

SELL
$5.22 - $9.08 $61,256 - $106,553
-11,735 Reduced 4.41%
254,485 $1.54 Million
Q1 2019

May 15, 2019

SELL
$5.35 - $9.82 $4,708 - $8,641
-880 Reduced 0.33%
266,220 $2.1 Million
Q4 2018

Feb 14, 2019

BUY
$3.43 - $6.19 $4,527 - $8,170
1,320 Added 0.5%
267,100 $1.33 Million
Q3 2018

Nov 14, 2018

SELL
$4.75 - $14.5 $1.45 Million - $4.44 Million
-306,105 Reduced 53.53%
265,780 $1.26 Million
Q2 2018

Aug 14, 2018

SELL
$13.3 - $17.45 $513,845 - $674,180
-38,635 Reduced 6.33%
571,885 $7.78 Million
Q1 2018

May 15, 2018

BUY
$14.7 - $24.95 $2.33 Million - $3.96 Million
158,658 Added 35.11%
610,520 $9.8 Million
Q4 2017

Feb 12, 2018

BUY
$19.9 - $29.25 $5.44 Million - $7.99 Million
273,146 Added 152.84%
451,862 $10.5 Million
Q3 2017

Nov 07, 2017

BUY
$15.1 - $19.25 $2.7 Million - $3.44 Million
178,716
178,716 $3.3 Million

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.